Pharmaceutical CDMO Market 2025 to 2034
Pharmaceutical CDMO Market 2025 to 2034
Pharmaceutical CDMO Market (By Service Type: Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Formulation (FDF) Development and Manufacturing, Secondary Packaging; By Research Phase: Pre-clinical, Phase I, Phase II, Phase III, Phase IV; By Region: North America, Latin America, Europe, Asia-Pacific, Middle and East Africa) Industry Size, Share, Growth, Trends 2025 to 2034.
Customisation Request
Revenue, 2025
USD 197.40 Bn
Forecast Year, 2034
USD 368.70 Bn
CAGR, 2025 - 2034
7.15%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global pharmaceutical CDMO market, valued at USD 197.40 billion in 2025, is projected to reach USD 368.70 billion by 2034, growing at a CAGR of 7.15%, driven by rising outsourcing of drug development and manufacturing services.
Pharmaceutical CDMO Market Size Analysis
Pharmaceutical CDMO Market Size By Research Phase 2025 to 2034 (USD Billion)
| Research Phase | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Pre-clinical | 42.64 | 47.17 | 53.62 | 60.07 | 61.62 | 65.90 | 72.37 | 74.41 | 74.42 | 81.45 |
| Phase I | 41.03 | 42.05 | 42.91 | 46.56 | 48.97 | 50.58 | 53.05 | 56.51 | 64.24 | 72.05 |
| Phase II | 50.70 | 54.73 | 58.73 | 64.86 | 71.36 | 77.73 | 82.81 | 91.09 | 94.37 | 97.56 |
| Phase III | 33.13 | 34.97 | 35.45 | 36.69 | 38.00 | 45.32 | 50.58 | 53.77 | 60.64 | 63.54 |
| Phase IV | 29.91 | 32.60 | 35.93 | 35.94 | 40.25 | 40.26 | 40.27 | 44.31 | 51.63 | 52.91 |
Pharmaceutical CDMO Market Size By Service Type 2025 to 2034 (USD Billion)
| Service Type | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| API Manufacturing | 70.27 | 76.82 | 81.72 | 91.84 | 97.35 | 100.53 | 110.74 | 114.28 | 120.61 | 125.51 |
| FDF Development & Manufacturing | 67.74 | 72.89 | 78.49 | 83.57 | 90.83 | 99.19 | 105.10 | 116.92 | 131.26 | 140.71 |
| Secondary Packaging | 59.38 | 61.80 | 66.43 | 67.42 | 72.03 | 79.09 | 82.91 | 88.90 | 91.12 | 101.30 |
Pharmaceutical CDMO Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 37.31 | 42.92 | 49.33 | 55.50 | 58.31 | 58.44 | 58.45 | 60.07 | 65.43 | 76.15 |
| Europe | 39.81 | 40.89 | 40.90 | 46.22 | 46.96 | 53.06 | 53.07 | 53.13 | 58.76 | 59.88 |
| Asia Pacific | 42.28 | 48.95 | 51.43 | 54.66 | 61.10 | 64.27 | 73.09 | 77.99 | 83.13 | 94.65 |
| Latin America | 40.42 | 40.43 | 40.44 | 40.45 | 44.62 | 48.03 | 56.16 | 57.77 | 57.78 | 61.75 |
| Middle East & Africa | 37.58 | 39.43 | 46.81 | 49.43 | 49.44 | 55.02 | 59.80 | 71.15 | 77.92 | 77.93 |
Pharmaceutical CDMO Market Size to Attain USD 368.70 Billion by 2034
The global pharmaceutical cdmo market size was calculated at USD 197.40 billion in 2025 and is predicted to attain around USD 368.70 billion by 2034 a CAGR of 7.15%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
